跳至主要内容
临床试验/CTRI/2026/01/100523
CTRI/2026/01/100523尚未招募3 期

A Randomized Controlled Clinical Trial To Study The Effect Of Kansya Shalaka Agnikarma In Pain Management Of Vatakantaka With Special Reference To Plantar Fasciitis

Dr Nikita Lalasaheb Elajale1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2026年1月31日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
Reduction in heel pain intensity in patients of Vatakantaka after Kansya Shalaka Agnikarma

研究概览

简要总结

In todays world, the prevalence of  vatakantaka has increased considerably, largely due to lifestyle modifications such as occupational demands, prolonged standing, inappropriate footwear, and changing fashion trends. Modern medicine has treatments like NSAIDs , local steroids and surgery for Plantar fasciitis. Although steroid injections may provide short-term pain relief, their effect is often temporary. However, prolonged use of NSAIDs can cause Ill effects such as gastritis etc. Ayurveda provides many options for pain management and among them Agnikarma is most effective. It is a simple, minimally invasive procedure that can be safely performed at the outpatient department (OPD) level. Conducting research to evaluate effect of Kansya shalaka Agnikarma in Vatakantaka is crucial for expanding our understanding of traditional remedies and their applications in modern healthcare. Such research helps bridge existing knowledge gaps and provides evidence-based insights into the therapeutic potential of Agnikarma in Vatakantaka. Including patients within age group of 40-60 years, who fullfill clinical diagnostic criteria for Plantar fasciitis. Patients are selected irrespective of sex, socio economic status and community helps in achieving a disease and representative sample, enhancing the generalizability of the study findings, written consent from patients ensures ethical compliance and transparency in the treatment process.  the calculated sample size is 35. Simple random technique will be used. Total 70 number of patients will be selected and divided into two groups named as Group A (trial group) and Group B (control group). Kansya shalaka Agnikarma (group A) and Tamra shalaka Agnikarma (group B) will be given to patients. Agnikarma will be done in single session on 1st day and Assessment on 4th day and 7th day . All SOP of Agnikarma will be strictly followed during and after the procedure. Result of study will drawn on the basis of criteria of assessment and statistical analysis. Discussion will be done on the basis of observations and result obtained during treatment. Summary will be drawn and whole thesis work will be summarised. Conclusion will be drawn strictly on the basis of statistical analysis and will be unbiased.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Diagnose patients exhibiting signs and symptoms of Vatakantaka, such as ruk (stiffness) and vedana (pain).
  • •Target patients aged 40–60 years, regardless of religion or caste.

排除标准

  • •Uncontrolled diabetes, hypertension, HIV, cardiac disease, cancer, or TB.
  • •Local skin infection at the Agnikarma site.
  • •Calcaneal stress fracture.
  • •Anarha (unsuitable candidates) of Agnikarma.

结局指标

主要结局

Reduction in heel pain intensity in patients of Vatakantaka after Kansya Shalaka Agnikarma

时间窗: 7 days

次要结局

  • Where the trial group stands in comparison with control group(18 months)

研究者

发起方
Dr Nikita Lalasaheb Elajale
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Nikita Lalasaheb Elajale

SMBT Ayurved College And Hospital

研究点 (1)

Loading locations...

相似试验